Body-on-a-chip simulation with gastrointestinal tract and liver tissues suggests that ingested nanoparticles have the potential to cause liver injury
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
The use of nanoparticles in medical applications is highly anticipated, and at the same time little is known about how these nanoparticles affect human tissues. Here we have simulated the oral uptake of 50 nm carboxylated polystyrene nanoparticles with a microscale body-on-a-chip system (also referred to as multi-tissue microphysiological system or micro Cell Culture Analog). Using the 'GI tract-liver-other tissues' system allowed us to observe compounding effects and detect liver tissue injury at lower nanoparticle concentrations than was expected from experiments with single tissues. To construct this system, we combined in vitro models of the human intestinal epithelium, represented by a co-culture of enterocytes (Caco-2) and mucin-producing cells (TH29-MTX), and the liver, represented by HepG2/C3A cells, within one microfluidic device. The device also contained chambers that together represented the liquid portions of all other organs of the human body. Measuring the transport of 50 nm carboxylated polystyrene nanoparticles across the Caco-2/HT29-MTX co-culture, we found that this multi-cell layer presents an effective barrier to 90.5 ± 2.9% of the nanoparticles. Further, our simulation suggests that a larger fraction of the 9.5 ± 2.9% nanoparticles that travelled across the Caco-2/HT29-MTX cell layer were not large nanoparticle aggregates, but primarily single nanoparticles and small aggregates. After crossing the GI tract epithelium, nanoparticles that were administered in high doses estimated in terms of possible daily human consumption (240 and 480 × 10(11) nanoparticles mL(-1)) induced the release of aspartate aminotransferase (AST), an intracellular enzyme of the liver that indicates liver cell injury. Our results indicate that body-on-a-chip devices are highly relevant in vitro models for evaluating nanoparticle interactions with human tissues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“At the same time, they overcame the inaccessibility of cystic organoids and clearance of cell debris by creating a perfusable culture of mini-intestines where cells are arranged to form tube-shaped epithelia and similar spatial arrangement as the in vivo tissue100.”
From Organoids (2022) · cites this paper as [100]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“creation of Intestine Chips can facilitate study of drug breakdown both alone and when coupled to other Organ Chips that also contribute to drug metabolism (eg, Liver Chip) and clearance (eg, Kidney Chip) in a human Body-on-a-Chip configuration.36, 37”
From Microfluidic Organ-on-a-Chip Models of Human Intestine (2018) · cites this paper as [37]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Pooling together different cells and/or organoids for bulk analysis can lead to inaccurate results3,70,100,204,207,208.”
From Organoids (2022) · cites this paper as [100]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Some devices integrated multiple chambers with different types of cells to measure PK and pharmacodynamics (PD) properties of drug compounds in vitro.35, 36, 37”
From Microfluidic Organ-on-a-Chip Models of Human Intestine (2018) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Physiological Parameters in Laboratory Animals and Humans
Davies, B., & Morris, T. (1993) · Pharmaceutical Research · doi:10.1023/a:1018943613122 · Cited by 2,926
Lundqvist, M., Stigler, J., Elia, G., Lynch, I., Cedervall, T., & Dawson, K. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805135105 · Cited by 2,823
Kim, H. J., Huh, D., Hamilton, G., & Ingber, D. E. (2012) · Lab on a Chip · doi:10.1039/c2lc40074j · Cited by 1,734
Treating metastatic cancer with nanotechnology
Schroeder, A., Heller, D. A., Winslow, M. M., Dahlman, J. E., Pratt, G. W., Langer, R., Jacks, T., & Anderson, D. G. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3180 · Cited by 1,159
Tzima, E. (2001) · The EMBO Journal · doi:10.1093/emboj/20.17.4639 · Cited by 569
A toxicologist guide to the diagnostic interpretation of hepatic biochemical parameters
Ramaiah, S. K. (2007) · Food and Chemical Toxicology · doi:10.1016/j.fct.2007.06.007 · Cited by 494
Revisiting lab-on-a-chip technology for drug discovery
Neužil, P., Giselbrecht, S., Länge, K., Huang, T. J., & Manz, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3799 · Cited by 487
Nanoparticle-induced surface reconstruction of phospholipid membranes
Wang, B., Zhang, L., Bae, S. C., & Granick, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807296105 · Cited by 469
Evaluation of nanoparticle immunotoxicity
Dobrovolskaia, M. A., Germolec, D. R., & Weaver, J. L. (2009) · Nature Nanotechnology · doi:10.1038/nnano.2009.175 · Cited by 368
Oral exposure to polystyrene nanoparticles affects iron absorption
Mahler, G. J., Esch, M. B., Tako, E., Southard, T. L., Archer, S. D., Glahn, R. P., & Shuler, M. L. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.3 · Cited by 340
Research works printed but not linked: 1
- Neui P Giselbrecht S Lange K Huang TJ Manz A Nature Reviews Drug Discovery 2012 11 620 632 22850786 PMC6493334
Cited by
Items 101–200 of 281
Clamping strategies for organ-on-a-chip devices
Carvalho, D. J., Moroni, L., & Giselbrecht, S. (2023) · Nature Reviews Materials · doi:10.1038/s41578-022-00523-z · Cited by 53
Shao, W., Xu, H., Zeng, K., Ye, M., Pei, R., & Wang, K. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04139-2 · Cited by 64
Forest, V., & Pourchez, J. (2023) · Environment International · doi:10.1016/j.envint.2023.108115 · Cited by 51
In Vitro Models for Studying Transport Across Epithelial Tissue Barriers
Arumugasaamy, N., Navarro, J., Leach, J. K., Kim, P. C. W., & Fisher, J. P. (2018) · Annals of Biomedical Engineering · doi:10.1007/s10439-018-02124-w · Cited by 53
Recent Advances in Microfluidic-Based Microphysiological Systems
Kang, S. (2021) · BioChip Journal · doi:10.1007/s13206-021-00043-y · Cited by 47
Organ-on-chip systems as a model for nanomedicine
Stavrou, M., Phung, N. B., Grimm, J., & Andreou, C. (2023) · Nanoscale · doi:10.1039/d3nr01661g · Cited by 51
Bu, W., Ye, C., Jin, Y., Wang, X., Jiang, M., Huang, R., Egbobe, J. O., Zhao, X., & Tang, J. (2024) · Toxics · doi:10.3390/toxics12120908 · Cited by 49
“Despite recent advancements, the lack of standardized methodologies continues to hinder progress in understanding their environmental and biological impacts.”
Advanced In Vitro Testing Strategies and Models of the Intestine for Nanosafety Research
Kämpfer, A. A. M., Busch, M., & Schins, R. P. F. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00079 · Cited by 47
Human liver model systems in a dish
Thompson, W. L., & Takebe, T. (2021) · Development Growth & Differentiation · doi:10.1111/dgd.12708 · Cited by 60
“For example, liver and intestine models- ona- chip have been able to mimic a first- pass metabolism system (Esch et al., 2014), liver and skin tissue chips (Wagner et al.”
BackgroundMethodCritical Considerations for the Design of Multi-Organ Microphysiological Systems (MPS)
Malik, M., Yang, Y., Fathi, P., Mahler, G. J., & Esch, M. B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.721338 · Cited by 43
“Tissues that typically only experience low mechanical shear due to interstitial fluidic flow in vivo, are not disturbed by such lowgrade, bidirectional shear (Esch et al., 2015).”
BackgroundSelf-citationJones, L. R., Wright, S., & Gant, T. W. (2023) · Toxicology Letters · doi:10.1016/j.toxlet.2023.08.011 · Cited by 47
A Laminated Microfluidic Device for Comprehensive Preclinical Testing in the Drug ADME Process
An, F., Qu, Y., Luo, Y., Fang, N., Liu, Y., Gao, Z., Zhao, W., & Lin, B. (2016) · Scientific Reports · doi:10.1038/srep25022 · Cited by 43
Models of the Gut for Analyzing the Impact of Food and Drugs
Fois, C. A. M., Le, T. Y. L., Schindeler, A., Naficy, S., McClure, D. D., Read, M. N., Valtchev, P., Khademhosseini, A., & Dehghani, F. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201900968 · Cited by 47
van Berlo, D., van de Steeg, E., Amirabadi, H. E., & Masereeuw, R. (2021) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2021.05.001 · Cited by 50
Microtechnology-Based Multi-Organ Models
Lee, S., & Sung, J. (2017) · Bioengineering · doi:10.3390/bioengineering4020046 · Cited by 42
“Image reprinted from [31] with the permission of The Royal Society of Chemistry.”
BackgroundMethodInfluentialAlavijeh, A. A., Barati, M. A., Barati, M., & Dehkordi, H. A. (2019) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2019.043 · Cited by 45
Microfluidics for personalized drug screening of cancer
Menon, N. V., Lim, S. B., & Lim, C. T. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.09.008 · Cited by 44
Eswaran, S. G., Narayan, H., & Vasimalai, N. (2021) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2021.102140 · Cited by 42
In vitro micro-physiological models for translational immunology
Ramadan, Q., & Gijs, M. A. M. (2015) · Lab on a Chip · doi:10.1039/c4lc01271b · Cited by 41
Usmani, S. M., Bremer‐Hoffmann, S., Cheyns, K., Cubadda, F., Dumit, V. I., Escher, S. E., Fessard, V., Gutleb, A. C., Léger, T., Liu, Y., et al. (2024) · EFSA Supporting Publications · doi:10.2903/sp.efsa.2024.en-8826 · Cited by 59
Evaluating Nanoparticles in Preclinical Research Using Microfluidic Systems
Zhu, D., Long, Q., Xu, Y., & Xing, J. (2019) · Micromachines · doi:10.3390/mi10060414 · Cited by 43
“(d) The body-on-a-chip system to study the oral uptake of 50 nm carboxylated polystyrene NPs and their induced liver injury (adapted with permission from [72]).”
BackgroundInfluentialXue, J., Blesso, C. N., & Luo, Y. (2022) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-060721-025159 · Cited by 45
Bredeck, G., Halamoda‐Kenzaoui, B., Bogni, A., Lipsa, D., & Bremer‐Hoffmann, S. (2021) · Environment International · doi:10.1016/j.envint.2021.106921 · Cited by 42
Wright, L., Barnes, T. J., & Prestidge, C. A. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119488 · Cited by 41
Recent Advances in Gut‐ and Gut–Organ‐Axis‐on‐a‐Chip Models
Kim, R., & Sung, J. H. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202302777 · Cited by 53
Gastrointestinal microphysiological systems
Blutt, S. E., Broughman, J. R., Zou, W. Y., Zeng, X., Karandikar, U. C., In, J. G., Zachos, N. C., Kovbasnjuk, O. N., Donowitz, M., & Estes, M. K. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217710638 · Cited by 43
Organoids, organs-on-chips and other systems, and microbiota
May, S., Evans, S., & Parry, L. (2017) · Emerging Topics in Life Sciences · doi:10.1042/etls20170047 · Cited by 36
Liver-on-chips for drug discovery and development
Mehta, V., Karnam, G., & Madgula, V. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101143 · Cited by 35
“Apart from bioavailability prediction, the liver-gut system has also been applied to study various diseases such as inflammatory bowel disease [139], air pollution-related metabolic disturbances [140], nanoparticle-induced liver injury [141], and hepatic steatosis [142].”
BackgroundMicroengineered Organ-on-a-chip Platforms towards Personalized Medicine
Kankala, R. K., Wang, S., & Chen, A. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190222143542 · Cited by 41
Pharmacokinetics‐On‐a‐Chip: In Vitro Microphysiological Models for Emulating of Drugs ADME
Ramadan, Q., Fardous, R. S., Hazaymeh, R., Alshmmari, S. K., & Zourob, M. M. (2021) · Advanced Biology · doi:10.1002/adbi.202100775 · Cited by 42
Multi-Organs-on-Chips for Testing Small-Molecule Drugs: Challenges and Perspectives
Çeçen, B., Karavasili, C., Nazir, M., Bhusal, A., Dogan, E., Shahriyari, F., Tamburacı, S., Büyüköz, M., Kozacı, L. D., & Miri, A. K. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101657 · Cited by 42
Sampaio, A. R., Maia, R., Ciardulli, M. C., Santos, H. A., & Sarmento, B. F. C. C. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102053 · Cited by 57
“…were Tthe presence of the GI tract tissue enhanced the sensitivity of the liver tissue to NP exposure, ingested NPs caused significant liver injury [183] Multi OoC (liver cancer-bone) HepG2 cells (bone chamber is hydroxyapatite) Chitosan (CS) NPs CSNP were formulated via the ionotropic gelation…”
InfluentialOrgans-on-chips and Its Applications
Sun, W., Chen, Y., Luo, G., Zhang, M., Zhang, H., Wang, Y., & Hu, P. (2016) · Chinese Journal of Analytical Chemistry · doi:10.1016/s1872-2040(16)60920-9 · Cited by 42
Novel Microfluidic Colon with an Extracellular Matrix Membrane
Wang, C., Tanataweethum, N., Karnik, S. J., & Bhushan, A. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00883 · Cited by 35
Liver microsystems in vitro for drug response
Lee, J.-H., Ho, K.-L., & Fan, S.-K. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0575-0 · Cited by 33
Sustainable removal of nano/microplastics in water by solar energy
Wang, P., Huang, Z., Chen, S., Jing, M., Ge, Z., Chen, J., Yang, S., Chen, J., & Fang, Y. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.131196 · Cited by 39
Judging the value of ‘liver-on-a-chip’ devices for prediction of toxicity
Starokozhko, V., & Groothuis, G. M. M. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1246537 · Cited by 33
Arayanarakool, R., Meyer, A. K., Helbig, L., Sánchez, S., & Schmidt, O. G. (2015) · Lab on a Chip · doi:10.1039/c5lc00024f · Cited by 33
3D Hepatic Organoid-Based Advancements in LIVER Tissue Engineering
Panwar, A., Das, P., & Tan, L. P. (2021) · Bioengineering · doi:10.3390/bioengineering8110185 · Cited by 36
“Release of aspartate aminotransferase was observed after exposure to nanoparticles to demonstrate the liver injury by nanoparticles [80].”
BackgroundKamei, K., Koyama, Y., Tokunaga, Y., Mashimo, Y., Yoshioka, M., Fockenberg, C., Mosbergen, R., Korn, O., Wells, C. A., & Chen, Y. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600893 · Cited by 31
Organ-on-a-Chip systems for new drugs development
Vargas, R., Medina, L., & Egurbide, A. (2021) · ADMET & DMPK · doi:10.5599/admet.942 · Cited by 35
“Therefore, these systems enable to observe how the organs are affected by the main compound and by the metabolites that might be generated under physiological conditions [11,67,68].”
BackgroundInfluentialRaasch, M., Fritsche, E., Kurtz, A., Bauer, M., & Mosig, A. S. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.06.008 · Cited by 29
A guide to nanosafety testing: Considerations on cytotoxicity testing in different cell models
Riebeling, C., Piret, J., Trouiller, B., Nelissen, I., Saout, C., Toussaint, O., & Haase, A. (2017) · NanoImpact · doi:10.1016/j.impact.2017.11.004 · Cited by 30
“Finally, cell models are being refined, and new developments such as microfluidic systems and organoids promise to allow more realistic models and to eliminate the species differences in toxicological data by using human cells (Esch et al. 2014; Tralau et al. 2015).”
BackgroundBal‐Öztürk, A., Miccoli, B., Avci‐Adali, M., Mogtader, F., Sharifi, F., Çeçen, B., Yaşayan, G., Braeken, D., & Alarçın, E. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190206195304 · Cited by 30
Jiang, J., Pieterman, C., Ertaylan, G., Peeters, R., & de Kok, T. M. C. M. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02585-5 · Cited by 34
Kim, J., Lee, H., Selimović, Š., Gauvin, R., & Bae, H. (2015) · Drug Safety · doi:10.1007/s40264-015-0284-x · Cited by 34
In Vitro Intestinal and Liver Models for Toxicity Testing
Orbach, S. M., Less, R. R., Kothari, A., & Rajagopalan, P. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00699 · Cited by 31
Hao, R., Shan, S., Yang, D., Zhang, H., Sun, Y., & Li, Z. (2023) · Nutrients · doi:10.3390/nu15020372 · Cited by 29
“We tested alanine aminotransferase (ALT) and aspartate aminotransferase (AST) to investigate the damaging effect of FFA on hepatocytes and the effect of purple corncob anthocyanins [30].”
MethodAdvances of microfluidic intestine-on-a-chip for analyzing anti-inflammation of food
Liang, D., Su, W., & Tan, M. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1875395 · Cited by 27
Evaluating nanomedicine with microfluidics
He, Z., Ranganathan, N., & Li, P. (2018) · Nanotechnology · doi:10.1088/1361-6528/aae18a · Cited by 27
Emerging trends in modeling human liver disease in vitro
Underhill, G. H., & Khetani, S. R. (2019) · APL Bioengineering · doi:10.1063/1.5119090 · Cited by 30
Theragnostic nanomotors: Successes and upcoming challenges
Ramachandran, R. V., Bhat, R., Saini, D. K., & Ghosh, A. (2021) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1736 · Cited by 26
Fabozzi, A., Sala, F. D., di Gennaro, M., Solimando, N., Pagliuca, M., & Borzacchiello, A. (2021) · Polymer Chemistry · doi:10.1039/d1py01077h · Cited by 27
Tumor-on-a-chip platforms for assessing nanoparticle-based cancer therapy
Wang, Y., Cuzzucoli, F., Escobar, A., Lu, S., Liang, L., & Wang, S. (2018) · Nanotechnology · doi:10.1088/1361-6528/aac7a4 · Cited by 29
Hu, W., Wang, Y., Han, J., Zhang, W., Chen, J., Li, X., & Wang, L. (2025) · Biomaterials Science · doi:10.1039/d4bm01273a · Cited by 30
Hu, W., Wang, C., Gao, D., & Liang, Q. (2022) · Journal of Applied Toxicology · doi:10.1002/jat.4320 · Cited by 28
“For example, as shown in Figure 4, Esch et al. used a “GI tract–liver–other tissues” body on a chip to evaluate interactions of NPs with human tissues (Esch et al., 2014).”
Fabrication of Concave Microwells and Their Applications in Micro-Tissue Engineering: A Review
Guo, W., Chen, Z., Feng, Z., Li, H., Zhang, M., Zhang, H., & Cui, X. Y. (2022) · Micromachines · doi:10.3390/mi13091555 · Cited by 27
“used a body model composed of gastrointestine, liver, fat, kidney and bone marrow for the evaluation of the interaction between ingested nanoparticles and human tissues [14].”
MethodMicrotechnology‐based organ systems and whole‐body models for drug screening
Lee, S. H., Ha, S. K., Choi, I., Choi, N., Park, T. H., & Sung, J. H. (2016) · Biotechnology Journal · doi:10.1002/biot.201500551 · Cited by 25
“[69] with permission of The Royal Society”
BackgroundKeeping It Organized: Multicompartment Constructs to Mimic Tissue Heterogeneity
Sanchez-Rubio, A., Jayawarna, V., Maxwell, E., Dalby, M. J., & Salmerón‐Sánchez, M. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202202110 · Cited by 26
Neurotoxic effects and cognitive decline induced by Aniline Blue dye in an in-vivo zebrafish model
Sudhakaran, G., Karthikeyan, R., Madesh, S., Dhaareshwar, V. N., Pachaiappan, R., Rajagopal, R., Soundharrajan, I., Namasivayam, S. K. R., & Arockiaraj, J. (2025) · Toxicology · doi:10.1016/j.tox.2025.154065 · Cited by 22
Modulation of Carbon Nanotubes' Perturbation to the Metabolic Activity of CYP3A4 in the Liver
Zhang, Y., Wang, Y., Liu, A., Xu, S. L., Zhao, B., Zhang, Y., Zou, H., Wang, W., Zhu, H., & Yan, B. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201504182 · Cited by 22
Advancements in Microfluidic Systems for the Study of Female Reproductive Biology
Bodke, V. V., & Burdette, J. E. (2021) · Endocrinology · doi:10.1210/endocr/bqab078 · Cited by 22
Microtechnology-based in vitro models: Mimicking liver function and pathophysiology
Lee, S. Y., Kim, D., Sung, J. H., & Sung, J. H. (2021) · APL Bioengineering · doi:10.1063/5.0061896 · Cited by 24
Zhang, S., Xu, G., Wu, J., Liu, X., Fan, Y. Z., Chen, J., Wallace, G. G., & Gu, Q. (2023) · Small Methods · doi:10.1002/smtd.202300685 · Cited by 28
Adams, A., Bulusu, R. K. M., Mukhitov, N., Mendoza-Cortés, J. L., & Roper, M. G. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.8b05798 · Cited by 21
Microfluidic analysis of heterotypic cellular interactions: A review of techniques and applications
Sakthivel, K., O’Brien, A., Kim, K., & Hoorfar, M. (2019) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2019.03.026 · Cited by 24
Lacombe, J., Soldevila, M., & Zenhausern, F. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.07.019 · Cited by 25
Microphysiological systems to study colorectal cancer: state-of-the-art
Ramos, P., Carvalho, M. R., Chen, W., Yan, L., Zhang, C., He, Y., Reis, R. L., & Oliveira, J. M. (2023) · Biofabrication · doi:10.1088/1758-5090/acc279 · Cited by 24
“Such devices have been utilized to study key functional and mechanical properties of several human organs, in a multidisciplinary effort involving bioengineers and biologists, including lung alveoli [5] and bronchioles [6], kidney tubules [7] and glomeruli [8], small intestine [9], liver [10], bone marrow [11], and th…”
BackgroundNanocarrier‐Based Drug Delivery Systems using Microfluidic‐Assisted Techniques
Alam, M. K. (2023) · Advanced NanoBiomed Research · doi:10.1002/anbr.202300041 · Cited by 24
The body-on-a-chip concept: possibilities and limitations
Reif, R. (2014) · EXCLI journal · doi:10.17877/de290r-7275 · Cited by 18
Sphabmixay, P., Raredon, M. S. B., Wang, A. J.-S., Lee, H., Hammond, P. T., Fang, N. X., & Griffith, L. G. (2021) · Biofabrication · doi:10.1088/1758-5090/ac23aa · Cited by 20
“While the field has established the detrimental effects of excessive shear forces above 500 mPa [20], the data linking a lower range of shear stress and hepatic function has been inconsistent, due in part to different culture formats, model interpretations, or donor variability, with some studies showing a beneficial…”
BackgroundKaur, H., & Kaur, H. (2025) · Journal of environmental chemical engineering · doi:10.1016/j.jece.2025.115664 · Cited by 18
Real-time assessment of nanoparticle-mediated antigen delivery and cell response
Cunha-Matos, C. A., Millington, O. R., Wark, A. W., & Zagnoni, M. (2016) · Lab on a Chip · doi:10.1039/c6lc00599c · Cited by 21
Application of chemical reaction engineering principles to “body‐on‐a‐chip” systems
Sung, J. H., Wang, Y. I., Kim, J. H., Lee, J. M., & Shuler, M. L. (2018) · AIChE Journal · doi:10.1002/aic.16448 · Cited by 18
Mortensen, N. P., Mercier, K., McRitchie, S., Cavallo, T. B., Pathmasiri, W., Stewart, D. A., & Sumner, S. (2016) · Biomedical Microdevices · doi:10.1007/s10544-016-0076-9 · Cited by 19
“…(Shintu et al. 2012, Prot et al. 2012), biomolecular interactions (Javanmard et al. 2010) and detection (Mok et al. 2014), nanoparticle exposure (Esch et al. 2014, Mahler et al. 2012), and in the field of nutrient research (Ramadan et al. 2013), there has been little effort to date to develop…”
BackgroundCiura, K., Moschini, E., Stepnik, M., Serchi, T., Gutleb, A. C., Jarzyńska, K., Jagiełło, K., & Puzyn, T. (2023) · Small · doi:10.1002/smll.202305581 · Cited by 17
Adolfsson, K., Abariūtė, L., Dabkowska, A. P., Schneider, M., Häcker, U., & Prinz, C. N. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2017.10.014 · Cited by 16
Pharmacokinetic-based multi-organ chip for recapitulating organ interactions
Sung, J. H. (2018) · Methods in cell biology · doi:10.1016/bs.mcb.2018.05.008 · Cited by 19
Low-temperature bonding process for the fabrication of hybrid glass–membrane organ-on-a-chip devices
Pocock, K. J., Gao, X., Wang, C., Priest, C., Prestidge, C. A., Mawatari, K., Kitamori, T., & Thierry, B. (2016) · Journal of Micro/Nanopatterning Materials and Metrology · doi:10.1117/1.jmm.15.4.044502 · Cited by 18
“mimic a range of different human organs and the intricate network of interactions.(5) The vast majority of microdevices”
BackgroundAdvanced Biomanufacturing Technologies for Micro-physiological Systems
Kim, M. K., Yoon, J., Kim, D., Kim, J., Kim, J.-S., Go, G., Song, J., Son, S., Park, K., Lee, J., et al. (2025) · International Journal of Precision Engineering and Manufacturing · doi:10.1007/s12541-025-01330-6 · Cited by 16
Recent approaches of toxicity-related attributes of NMs: A systematic review
Chaudhari, N. B., Shinde, S., Havelikar, U. A., Desai, S. A., & Patel, V. P. (2025) · Nano Trends · doi:10.1016/j.nwnano.2025.100160 · Cited by 19
Body-on-a-Chip Systems for Animal-free Toxicity Testing
Mahler, G. J., Esch, M. B., Stokol, T., Hickman, J. J., & Shuler, M. L. (2016) · Alternatives to Laboratory Animals · doi:10.1177/026119291604400508 · Cited by 16
“The basis of the 2015 Lush Science Prize award was an in vitro system, built in 2014, that was capable of mimicking the oral uptake and firstpass metabolism of drugs and drug carriers in humans (10).”
BackgroundJabri, A., Khan, J. A., Taftafa, B., Alsharif, M., Mhannayeh, A., Chinnappan, R., Alzhrani, A., Kazmi, S., Mir, M. S., Alsaud, A. W., et al. (2024) · Bioengineering · doi:10.3390/bioengineering11040346 · Cited by 15
“Interestingly, linking the intestine compartment to the liver compartment via microfluidic channels exacerbated this effect, resembling the first-pass metabolism despite reducing nanoparticle exposure in the Liver Chip [118].”
BackgroundKobayashi, Y., Hashizume, H., Takiguchi, S., Ji, J., Kawano, R., Koiwai, K., Yamamoto, H., Elbadawy, M., Omatsu, T., Abugomaa, A., et al. (2025) · Scientific Reports · doi:10.1038/s41598-024-84297-0 · Cited by 23
Samantasinghar, A., Sunildutt, N., Ahmed, F., Memon, F. H., Kang, C.-U., & Choi, K. H. (2025) · ACS Omega · doi:10.1021/acsomega.4c11227 · Cited by 19
Computational pharmacokinetic modeling of organ-on-chip devices and microphysiological systems
Przekwas, A. J., & Somayaji, M. R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817202-5.00011-5 · Cited by 15
Cells and Organs on Chip—A Revolutionary Platform for Biomedicine
Joshi, P. N. (2016) · InTech eBooks · doi:10.5772/64102 · Cited by 18
Huang, T. H., Huang, W. T., & Bian, Q. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114222 · Cited by 14
Bioinspired Engineering of Organ-on-Chip Devices
Wang, L., Li, Z., Xu, C., & Qin, J. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9791-2_13 · Cited by 14
Gutleb, A. C., Murugadoss, S., Stepnik, M., SenGupta, T., Yamani, N. E., Longhin, E., Olsen, A.-K. H., Wyrzykowska, E., Jagiełło, K., Judzińska, B., et al. (2025) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2025.503867 · Cited by 17
Mahdavi, R., Hashemi‐Najafabadi, S., Ghiass, M. A., Valaskivi, S., Välimäki, H., Kreutzer, J., Blomqvist, C. H., Romeo, S., Kallio, P. J., & Adiels, C. B. (2025) · Biomedical Microdevices · doi:10.1007/s10544-025-00738-1 · Cited by 14
Organ-On-A-Chip Database Revealed—Achieving the Human Avatar in Silicon
Jiang, L., Li, Q., Liang, W., Du, X., Yang, Y., Zhang, Z., Xu, L., Zhang, J., Li, J., Chen, Z., et al. (2022) · Bioengineering · doi:10.3390/bioengineering9110685 · Cited by 17
“OOC models that can be applied to PBPK model analysis have been developed [107,108], and using OOC experimental data for in vitro to in vivo extrapolation (IVIVE) has been pro‐ posed.”
MethodGarziano, A., Urciuolo, F., Imparato, G., Martorina, F., Corrado, B., & Netti, P. A. (2016) · Lab on a Chip · doi:10.1039/c5lc01481f · Cited by 13
Sensor-free and Sensor-based Heart-on-a-chip Platform: A Review of Design and Applications
Wan, H., Gu, C., Gan, Y., Wei, X., Zhu, K., Hu, N., & Wang, P. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190207170004 · Cited by 14
Body-on-a-chip systems: Design, fabrication, and applications
Esch, M. B., & Mahler, G. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813671-3.00011-6 · Cited by 16
Jin, H., & Yu, Y. (2015) · SLAS TECHNOLOGY · doi:10.1177/2211068215619126 · Cited by 13
“This improved intestine mCCA was tested with an iron bioavailability experiment,(75) a toxicity experiment of acetaminophen,(61) and a toxicity experiment of nanoparticles.(76) Data obtained by this mCCA system were consistent with in vivo measurements using mice, indicating that this mCCA system could be broadly used…”
MethodMéndez‐Rodríguez, K. B., Avalos, J. A. J., Fernández-Macías, J. C., & González-Palomo, A. K. (2023) · Environmental Science and Pollution Research · doi:10.1007/s11356-023-30853-6 · Cited by 14
Maschmeyer, I., & Kakava, S. (2020) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2020_135 · Cited by 16
Biomimetic microfluidic chips for toxicity assessment of environmental pollutants
Du, X.-Y., & Yang, J. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.170745 · Cited by 13
Zhao, Y., Yin, N., Yang, R., & Faiola, F. (2024) · Food and Chemical Toxicology · doi:10.1016/j.fct.2024.115022 · Cited by 14
Metadata
- Authors
- Esch, M. B., Mahler, G. J., Stokol, T., & Shuler, M. L.
- Affiliations
- Cornell University (US)
- Binghamton University (US)
- Corresponding author
- Shuler, Michael L.
- Venue
- Lab Chip
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2014
- Volume
- 14
- Issue
- 16
- Pages
- 3081-3092
- ISSN
- 1473-0189 (ISSN-L)
- 1473-0197
- PMC
- PMC4144667
- OpenAlex
- W2030338281
- Cited by
- 281
- References
- 37
- Citations by year
- 2026: 11 · 2025: 24 · 2024: 16 · 2023: 30 · 2022: 20 · 2021: 27 · 2020: 23 · 2019: 28 · 2018: 30 · 2017: 25 · 2016: 31 · 2015: 12 · 2014: 4
- FWCI
- 10.88
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Lab on a Chip (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Science Foundation
- National Institutes of Health (UH2TR000516)
- National Center for Advancing Translational Sciences
- U.S. Army Corps of Engineers
- Topics
- Physical Sciences › Materials Science › Materials Chemistry › Nanoparticles: synthesis and applications
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
- Keywords
- body-on-a-chip, organ-on-a-chip, gastrointestinal tract, liver injury, Caco-2/HT29-MTX co-culture, intestinal epithelial barrier, nanoparticle transport, nanoparticle aggregation, nanoparticle toxicity
- MeSH terms
- Analysis of Variance, Cell Line, Cell Survival, Humans, Intestinal Mucosa, Liver, Models, Biological, Toxicity Tests, Cell Culture Techniques, Gastrointestinal Tract, Microfluidic Analytical Techniques, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.